12.07.2015 Views

marker-assisted selection in wheat - ictsd

marker-assisted selection in wheat - ictsd

marker-assisted selection in wheat - ictsd

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

12Marker-<strong>assisted</strong> <strong>selection</strong> – Current status and future perspectives <strong>in</strong> crops, livestock, forestry and fishhave their limitations, they have shownover time that they can be highly successful.Application of MAS will not occur <strong>in</strong> avacuum and the potential benefits (genetic,economic, etc.) of us<strong>in</strong>g MAS need to becompared with those achieved or expectedfrom any exist<strong>in</strong>g conventional breed<strong>in</strong>gprogrammes.In the different agricultural sectors, thisquestion has received much attention fromresearchers. There seems to be general consensusthat the relative success of MAScompared with conventional breed<strong>in</strong>g maydepend on the k<strong>in</strong>d of trait (or traits) to begenetically improved. If the trait is difficultto record or is not rout<strong>in</strong>ely recorded<strong>in</strong> conventional programmes, MAS willoffer more advantages than if it is rout<strong>in</strong>elyrecorded. Similarly, if the trait is sex-limitedor can only be measured late <strong>in</strong> life thenMAS is favoured, as <strong>marker</strong> <strong>in</strong>formationcan be used <strong>in</strong> both sexes and at any age.In consider<strong>in</strong>g the merits of MAS versusconventional breed<strong>in</strong>g, it is also importantto keep <strong>in</strong> m<strong>in</strong>d that the existence ofa strong breed<strong>in</strong>g programme is a prerequisitefor the application of advancedmolecular technologies such as MAS. Insituations where the <strong>in</strong>frastructure andcapacity are <strong>in</strong>sufficient to support a successfulconventional breed<strong>in</strong>g programme,MAS will not provide a shortcut to geneticimprovement.MAS versus other biotechnologies forgenetic improvementThe relative costs and benefits of apply<strong>in</strong>gMAS should be compared not onlywith conventional breed<strong>in</strong>g but also withthe use of other new technologies that canpotentially improve agricultural populationsgenetically. These <strong>in</strong>clude tissue culture<strong>in</strong> crops and forest trees, reproductivetechnologies (e.g. embryo transfer or clon<strong>in</strong>g)<strong>in</strong> livestock and triploidization or sexreversal<strong>in</strong> farmed fish. They also <strong>in</strong>cludegenetic modification, a technology that canbe applied to all sectors. Compared withgenetic modification, regulation of MAS,be it at the level of research and development,field test<strong>in</strong>g, commercial release orimport/export of developed products, ismore relaxed; <strong>in</strong> addition, public acceptanceof the technology is not an issue.Intellectual property rights issuesAs discussed <strong>in</strong> Conference 6 of the FAOBiotechnology Forum (FAO, 2001), theissue of <strong>in</strong>tellectual property rights (IPRs)is play<strong>in</strong>g an ever greater role <strong>in</strong> foodand agriculture <strong>in</strong> develop<strong>in</strong>g countries.Participants <strong>in</strong> that conference, <strong>in</strong>ter alia,suggested that this issue was hav<strong>in</strong>g a generallynegative <strong>in</strong>fluence on the quality ofagricultural research carried out and on thenature of research collaborations betweenthe public and private sector and betweendevelop<strong>in</strong>g and developed countries.It is therefore obvious that IPRs mayalso have an impact on the development andapplication of MAS <strong>in</strong> develop<strong>in</strong>g countries.For example, the AFLP molecular <strong>marker</strong>mapp<strong>in</strong>g technique is patented. Molecular<strong>marker</strong>s can be patented, although this canoften be overcome by us<strong>in</strong>g other <strong>marker</strong>snear the gene of <strong>in</strong>terest. Individual genescan also be patented. With IPRs, however,there is nevertheless public disclosure ofthe <strong>in</strong>vention or <strong>in</strong>formation. Non-disclosureof <strong>in</strong>formation, where patents are notsought but the <strong>in</strong>formation on <strong>marker</strong>s ordetected QTL is nevertheless kept secret,can also have negative impacts, by deny<strong>in</strong>gdevelop<strong>in</strong>g countries access to potentiallyuseful <strong>in</strong>formation.More details on IPRs and MAS can befound <strong>in</strong> Chapter 20.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!